Federal Register / Vol. 63, No. 18 /Wednesday, January 28, 1998 / Notices 4307

MS T8F5, Washington, DC 20555,

Telephone (301) 415–6376.

Conduct of the Meeting

Mr. Dennis Swanson will chair the

meeting. Mr. Dennis Swanson will

conduct the meeting in a manner that

will facilitate the orderly conduct of

business. The following procedures

apply to public participation in the

meeting:

1. Persons who wish to provide a

written statement should submit a

reproducible copy to Patricia Vacherlon

(address listed previously), by February

2, 1998. Statements must pertain to the

topics on the agenda for the meeting.

2. At the meeting, questions from

members of the public will be permitted

at the discretion of the Chairman.

3. The transcript and written

comments will be available for

inspection, and copying, for a fee, at the

NRC Public Document Room, 2120 L

Street, NW., Lower Level, Washington,

DC 20555, telephone (202) 634–3273, on

or about April 1, 1998. Minutes of the

meeting will be available on or about

May 1, 1998.

4. Seating for the public will be on a

first-come, first-served basis.

This meeting will be held in

accordance with the Atomic Energy Act

of 1954, as amended (primarily Section

161a); the Federal Advisory Committee

Act (5 U.S.C. App); and the

Commission’s regulations in Title 10,

U.S. Code of Federal Regulations, part 7.

Dated: January 22, 1998.

Andrew L. Bates,

Advisory Committee Management Officer.

[FR Doc. 98–2019 Filed 1–27–98; 8:45 am]

BILLING CODE 7590–01–P

NUCLEAR REGULATORY

COMMISSION

Advisory Committee on the Medical

Uses of Isotopes: Meeting Notice

AGENCY: Nuclear Regulatory

Commission.

ACTION: Notice of meeting.

SUMMARY: The U.S. Nuclear Regulatory

Commission will convene a meeting of

the Advisory Committee on the Medical

Uses of Isotopes (ACMUI) on March 1–

2, 1998. The meeting will take place at

the address provided below. All

sessions of the meeting will be open to

the public.

Topics of discussion will include: (1)

An update on the revision of 10 CFR

part 35 and associated activities to

include a detailed discussion on the

proposed rule text; (2) a discussion of

the committee’s response to the

Commission’s request for the ACMUI to

take a focused look at revisions to part

35; (3) a discussion of the committee’s

response to the Commission’s request

for the ACMUI to identify criteria for

evaluation of committee performance;

(4) a discussion of the calibration and

the correct use of Strontium-90 eye

applicators; (5) a discussion of current

training and experience requirements to

conduct intravascular brachytherapy; (6)

a discussion of previous ACMUI

recommendations.

DATES: The meeting will begin at 8 a.m.,

on March 1 and 2, 1998.

ADDRESSES: U.S. Nuclear Regulatory

Commission, Two White Flint North,

11545 Rockville Pike, Room T2B3,

Rockville, MD 20852–2738.

FOR FURTHER INFORMATION, CONTACT:

Patricia Vacherlon, U.S. Nuclear

Regulatory Commission, Office of

Nuclear Material Safety and Safeguards,

MS T8F5, Washington, DC 20555,

Telephone (301) 415–6376.

Conduct of the Meeting

Judith Ann Stitt, M.D., will chair the

meeting. Dr. Stitt will conduct the

meeting in a manner that will facilitate

the orderly conduct of business. The

following procedures apply to public

participation in the meeting:

1. Persons who wish to provide a

written statement should submit a

reproducible copy to Patricia Vacherlon

(address listed previously), by February

20, 1998. Statements must pertain to the

topics on the agenda for the meeting.

2. At the meeting, questions from

members of the public will be permitted

at the discretion of the Chairman.

3. The transcript and written

comments will be available for

inspection, and copying, for a fee, at the

NRC Public Document Room, 2120 L

Street, N.W., Lower Level, Washington,

DC 20555, telephone (202) 634–3273, on

or about April 1, 1998. Minutes of the

meeting will be available on or about

May 1, 1998.

4. Seating for the public will be on a

first-come, first-served basis.

This meeting will be held in

accordance with the Atomic Energy Act

of 1954, as amended (primarily Section

161a); the Federal Advisory Committee

Act (5 U.S.C. App); and the

Commission’s regulations in Title 10,

Code of Federal Regulations, Part 7.

Dated: January 23, 1998.

Andrew L. Bates,

Advisory Committee Management Officer.

[FR Doc. 98–2080 Filed 1–27–98; 8:45 am]

BILLING CODE 7590–01–P

NUCLEAR REGULATORY

COMMISSION

Public Workshop: Demonstrating

Compliance With the Radiological

Criteria for License Termination—

Methods to Conduct a Final Status

Survey and Dose Modeling

AGENCY: Nuclear Regulatory

Commission (NRC).

ACTION: Notice of workshop.

SUMMARY: The NRC will hold a public

workshop in Rockville, Maryland to

receive input from licensees and the

public on working papers on ‘‘Methods

to Conduct a Final Status Survey,’’ and

‘‘Dose Modeling.’’ These working papers

are being developed as part of a future

Regulatory Guide. The Regulatory Guide

is being written to describe an

acceptable method to comply with the

NRC’s recent final rule on Radiological

Criteria for License Termination (62 FR

39058; July 21, 1997). These working

papers have received only limited NRC

staff review or approval. The purpose of

the workshop is to obtain comments,

suggestions, and information from the

public on the approach in the working

papers so that a better Regulatory Guide

can be developed. All interested

licensees and members of the public are

invited to attend this workshop.

DATES: The workshop will be held on

February 18 and 19, 1998, beginning at

9 a.m. and ending at about 5 p.m. There

is no pre-registration. Interested parties,

unable to attend the workshop, are

encouraged to provide written

comments by March 13, 1998.

ADDRESSES: The public workshop will

be held in the NRC’s auditorium at Two

White Flint North, 11545 Rockville

Pike, Rockville, Maryland. Visitor

parking around the NRC building is

limited; however, the workshop site is

located adjacent to the White Flint

Station on the Metro Red Line. A

transcript of this workshop will be

available for inspection, and copying for

a fee at the NRC Public Document

Room, 2120 L Street, NW., Lower Level,

Washington, DC 20555, on or about

March 2, 1998.

Obtaining the Working Paper

Copies of the draft working papers to

be discussed will be made available

electronically, prior to the workshop, at

the NRC Technical Conference Forum

Website under the topic ‘‘Final Rule for

License Termination’’ at http: //

techconf.llnl.gov/cgi-bin/topics or from

the NRC’s Public Document Room, 2120

L Street, NW., (Lower Level),

Washington, DC 20555; telephone 202–

634–3273; fax 202–634–3343. To view
4308 Federal Register / Vol. 63, No. 18 /Wednesday, January 28, 1998 / Notices

the working papers at the Website,

select ‘‘Final Rule on Radiological

Criteria for License Termination,’’ then

select ‘‘Lic Term Document Library,’’

then select ‘‘Regulatory Guide,’’ and

then select ‘‘Module C.2: Regulatory

Position—Final Status Survey,’’ or

‘‘Module C.1: Regulatory Position—Dose

Modeling.’’

Meeting Agenda

9:00 Welcome and introduction

9:05 Presentation describing issues

considered in developing the draft

working paper

10:30 Break

10:45 Public comments on the draft

working paper. Attendees will be

asked for questions and comments

on each section of the draft working

paper.

12:00 Lunch

1:30 Continuation of public comments.

5:00 Adjourn

Submitting Written Comments

Comments may be posted

electronically on the NRC Technical

Conference Forum Website mentioned

above. Comments submitted

electronically can also be viewed at that

Website. Comments may also be mailed

to the Chief, Rules and Directives

Branch, U.S. Nuclear Regulatory

Commission, Washington, DC 20555.

FOR FURTHER INFORMATION: For

information or questions on meeting

arrangements, contact Nina Barnett,

Office of Nuclear Regulatory Research,

U.S. Nuclear Regulatory Commission,

Washington, DC 20555, telephone 301–

415–6187, fax 301–415–5385, E-mail:

NMB@NRC.GOV. For technical

information or questions, contact

Stephen A. McGuire, Office of Nuclear

Regulatory Research, U.S. Nuclear

Regulatory Commission, Washington,

DC 20555, telephone 301–415–6204;

fax: 301–415–5385; E-mail:

SAM2@NRC.GOV.

Dated at Rockville, Maryland this 22nd day

of January, 1998.

For the Nuclear Regulatory Commission.

Cheryl Trottier,

Chief, Radiation Protection and Health Effects

Branch, Division of Regulatory Applications,

RES.

[FR Doc. 98–2017 Filed 1–27–98; 8:45 am]

BILLING CODE 7590–01–P

NUCLEAR REGULATORY

COMMISSION

Biweekly Notice; Applications and

Amendments to Facility Operating

Licenses Involving No Significant

Hazards Considerations

I. Background

Pursuant to Public Law 97–415, the

U.S. Nuclear Regulatory Commission

(the Commission or NRC staff) is

publishing this regular biweekly notice.

Public Law 97–415 revised section 189

of the Atomic Energy Act of 1954, as

amended (the Act), to require the

Commission to publish notice of any

amendments issued, or proposed to be

issued, under a new provision of section

189 of the Act. This provision grants the

Commission the authority to issue and

make immediately effective any

amendment to an operating license

upon a determination by the

Commission that such amendment

involves no significant hazards

consideration, notwithstanding the

pendency before the Commission of a

request for a hearing from any person.

This biweekly notice includes all

notices of amendments issued, or

proposed to be issued from January 5,

1998, through January 15, 1998. The last

biweekly notice was published on

January 14, 1998 (63 FR 2271).

Notice of Consideration of Issuance of

Amendments to Facility Operating

Licenses, Proposed No Significant

Hazards Consideration Determination,

and Opportunity for a Hearing

The Commission has made a

proposed determination that the

following amendment requests involve

no significant hazards consideration.

Under the Commission’s regulations in

10 CFR 50.92, this means that operation

of the facility in accordance with the

proposed amendment would not (1)

involve a significant increase in the

probability or consequences of an

accident previously evaluated; or (2)

create the possibility of a new or

different kind of accident from any

accident previously evaluated; or (3)

involve a significant reduction in a

margin of safety. The basis for this

proposed determination for each

amendment request is shown below.

The Commission is seeking public

comments on this proposed

determination. Any comments received

within 30 days after the date of

publication of this notice will be

considered in making any final

determination.

Normally, the Commission will not

issue the amendment until the

expiration of the 30-day notice period.

However, should circumstances change

during the notice period such that

failure to act in a timely way would

result, for example, in derating or

shutdown of the facility, the

Commission may issue the license

amendment before the expiration of the

30-day notice period, provided that its

final determination is that the

amendment involves no significant

hazards consideration. The final

determination will consider all public

and State comments received before

action is taken. Should the Commission

take this action, it will publish in the

Federal Register a notice of issuance

and provide for opportunity for a

hearing after issuance. The Commission

expects that the need to take this action

will occur very infrequently.

Written comments may be submitted

by mail to the Chief, Rules and

Directives Branch, Division of

Administration Services, Office of

Administration, U.S. Nuclear Regulatory

Commission, Washington, DC 20555–

0001, and should cite the publication

date and page number of this Federal

Register notice. Written comments may

also be delivered to Room 6D22, Two

White Flint North, 11545 Rockville

Pike, Rockville, Maryland from 7:30

a.m. to 4:15 p.m. Federal workdays.

Copies of written comments received

may be examined at the NRC Public

Document Room, the Gelman Building,

2120 L Street, NW., Washington, DC.

The filing of requests for a hearing and

petitions for leave to intervene is

discussed below.

By February 27, 1998, the licensee

may file a request for a hearing with

respect to issuance of the amendment to

the subject facility operating license and

any person whose interest may be

affected by this proceeding and who

wishes to participate as a party in the

proceeding must file a written request

for a hearing and a petition for leave to

intervene. Requests for a hearing and a

petition for leave to intervene shall be

filed in accordance with the

Commission’s ‘‘Rules of Practice for

Domestic Licensing Proceedings’’ in 10

CFR Part 2. Interested persons should

consult a current copy of 10 CFR 2.714

which is available at the Commission’s

Public Document Room, the Gelman

Building, 2120 L Street, NW.,

Washington, DC and at the local public

document room for the particular

facility involved. If a request for a

hearing or petition for leave to intervene

is filed by the above date, the

Commission or an Atomic Safety and

Licensing Board, designated by the

Commission or by the Chairman of the

Atomic Safety and Licensing Board

Panel, will rule on the request and/or